STRAUM.HLD.UNSP.ADR/1/10 (QS50) - Net Assets
Based on the latest financial reports, STRAUM.HLD.UNSP.ADR/1/10 (QS50) has net assets worth €2.16 Billion EUR (≈ $2.53 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€3.76 Billion ≈ $4.39 Billion USD) and total liabilities (€1.59 Billion ≈ $1.86 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check QS50 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €2.16 Billion |
| % of Total Assets | 57.6% |
| Annual Growth Rate | 9.6% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 8.93 |
STRAUM.HLD.UNSP.ADR/1/10 - Net Assets Trend (2021–2025)
This chart illustrates how STRAUM.HLD.UNSP.ADR/1/10's net assets have evolved over time, based on quarterly financial data. See STRAUM.HLD.UNSP.ADR/1/10 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for STRAUM.HLD.UNSP.ADR/1/10 (2021–2025)
The table below shows the annual net assets of STRAUM.HLD.UNSP.ADR/1/10 from 2021 to 2025. For live valuation and market cap data, see STRAUM.HLD.UNSP.ADR/1/10 market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €2.16 Billion ≈ $2.53 Billion |
+5.92% |
| 2024-12-31 | €2.04 Billion ≈ $2.39 Billion |
+11.16% |
| 2023-12-31 | €1.84 Billion ≈ $2.15 Billion |
-0.82% |
| 2022-12-31 | €1.85 Billion ≈ $2.17 Billion |
+23.55% |
| 2021-12-31 | €1.50 Billion ≈ $1.75 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to STRAUM.HLD.UNSP.ADR/1/10's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 92.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €2.88 Billion | 133.12% |
| Total Equity | €2.16 Billion | 100.00% |
STRAUM.HLD.UNSP.ADR/1/10 Competitors by Market Cap
The table below lists competitors of STRAUM.HLD.UNSP.ADR/1/10 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Taishin Financial Holding Co Ltd Pref
TW:2887E
|
$16.60 Billion |
|
Knorr-Bremse AG
F:KBX
|
$16.64 Billion |
|
Carlyle Group Inc
NASDAQ:CG
|
$16.65 Billion |
|
YPF Sociedad Anónima
F:YPF
|
$16.68 Billion |
|
Samsung Heavy Industries
KO:010140
|
$16.58 Billion |
|
mBank SA
WAR:MBK
|
$16.57 Billion |
|
Xiamen Tungsten Co Ltd
SHG:600549
|
$16.56 Billion |
|
Heineken Holding NV
AS:HEIO
|
$16.55 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in STRAUM.HLD.UNSP.ADR/1/10's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,040,131,000 to 2,160,510,000, a change of 120,379,000 (5.9%).
- Net income of 355,916,000 contributed positively to equity growth.
- Dividend payments of 151,340,000 reduced retained earnings.
- Share repurchases of 24,559,000 reduced equity.
- New share issuances of 11,888,000 increased equity.
- Other factors decreased equity by 71,526,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €355.92 Million | +16.47% |
| Dividends Paid | €151.34 Million | -7.0% |
| Share Repurchases | €24.56 Million | -1.14% |
| Share Issuances | €11.89 Million | +0.55% |
| Other Changes | €-71.53 Million | -3.31% |
| Total Change | €- | 5.90% |
Book Value vs Market Value Analysis
This analysis compares STRAUM.HLD.UNSP.ADR/1/10's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.66x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.95x to 0.66x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €9.40 | €8.90 | x |
| 2022-12-31 | €11.62 | €8.90 | x |
| 2023-12-31 | €11.52 | €8.90 | x |
| 2024-12-31 | €12.79 | €8.90 | x |
| 2025-12-31 | €13.55 | €8.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently STRAUM.HLD.UNSP.ADR/1/10 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 16.47%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 13.66%
- • Asset Turnover: 0.69x
- • Equity Multiplier: 1.74x
- Recent ROE (16.47%) is below the historical average (19.78%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 26.49% | 19.59% | 0.68x | 1.98x | €246.54 Million |
| 2022 | 23.48% | 18.73% | 0.69x | 1.82x | €249.63 Million |
| 2023 | 13.40% | 10.81% | 0.69x | 1.81x | €62.45 Million |
| 2024 | 19.03% | 15.51% | 0.69x | 1.77x | €184.30 Million |
| 2025 | 16.47% | 13.66% | 0.69x | 1.74x | €139.87 Million |
Industry Comparison
This section compares STRAUM.HLD.UNSP.ADR/1/10's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $6,655,403,596
- Average return on equity (ROE) among peers: -5.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| STRAUM.HLD.UNSP.ADR/1/10 (QS50) | €2.16 Billion | 26.49% | 0.74x | $16.59 Billion |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $2.39 Billion |
| RENAU.UNSP.ARD 1/5 EO-20 (56S0) | $2.67 Billion | 11.61% | 1.89x | $15.47 Billion |
| MEDIMI AB AK (79T) | $15.24 Million | -107.34% | 0.16x | $365.27K |
| TEVANO SYSTEMS HLDGS INC. (7RBA) | $-736.70K | 0.00% | 0.00x | $210.67K |
| STEVANATO GROUP SPA O.N. (87N) | $1.40 Billion | 8.39% | 0.66x | $831.06 Million |
| Carl Zeiss Meditec AG (AFX) | $1.42 Billion | 11.27% | 0.43x | $2.23 Billion |
| CARL ZEISS MEDITEC ADR 1 (AFXA) | $2.03 Billion | 14.48% | 0.39x | $2.14 Billion |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $6.81 Million |
| COLOPLAST SP.ADR 1/10 DK1 (CBH) | $17.30 Billion | 27.65% | 1.78x | $12.73 Billion |
| ESSILORLUXOTTICA 1/2/O.N. (ESLC) | $41.00 Billion | 5.75% | 0.57x | $78.07 Billion |
About STRAUM.HLD.UNSP.ADR/1/10
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company also offers dental implants and components made f… Read more